Evaluation of Combination Therapy (75 mg/day Naftopidil plus 30 mg/day Urapidil) in Patients with BPH/LUTS Poorly Responding to alpha1 Blocker Monotherapy

Abstract Category

Benign Prostatic Hyperplasia (BPH)

Links
	Abstract 641
	Read by Title Scientific Non Discussion Abstract Session 31
	1. Department of Urology, Nagasaki University School of Medicine
Abstract PDF Edit Abstract Abstract Centre